177 related articles for article (PubMed ID: 21152092)
1. A full pharmacological analysis of the three turkey β-adrenoceptors and comparison with the human β-adrenoceptors.
Baker JG
PLoS One; 2010 Nov; 5(11):e15487. PubMed ID: 21152092
[TBL] [Abstract][Full Text] [Related]
2. The pharmacological effects of the thermostabilising (m23) mutations and intra and extracellular (β36) deletions essential for crystallisation of the turkey β-adrenoceptor.
Baker JG; Proudman RG; Tate CG
Naunyn Schmiedebergs Arch Pharmacol; 2011 Jul; 384(1):71-91. PubMed ID: 21547538
[TBL] [Abstract][Full Text] [Related]
3. Characterization of beta-adrenoceptors responsible for venom production in the venom gland of the snake Bothrops jararaca.
Yamanouye N; Carneiro SM; Scrivano CN; Markus RP
Life Sci; 2000 Jun; 67(3):217-26. PubMed ID: 10983865
[TBL] [Abstract][Full Text] [Related]
4. Identification of key residues in transmembrane 4 responsible for the secondary, low-affinity conformation of the human β1-adrenoceptor.
Baker JG; Proudman RG; Hill SJ
Mol Pharmacol; 2014 May; 85(5):811-29. PubMed ID: 24608857
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the binding affinity of some newly synthesized phenylethanolamine and phenoxypropanolamine compounds at recombinant human beta- and alpha1-adrenoceptor subtypes.
Ahmed M; Hanaoka Y; Kiso T; Kakita T; Ohtsubo Y; Muramatsu I; Nagatomo T
J Pharm Pharmacol; 2005 Jan; 57(1):75-81. PubMed ID: 15638996
[TBL] [Abstract][Full Text] [Related]
6. Comparison of three radioligands for the labelling of human beta-adrenoceptor subtypes.
Niclauss N; Michel-Reher MB; Alewijnse AE; Michel MC
Naunyn Schmiedebergs Arch Pharmacol; 2006 Nov; 374(2):99-105. PubMed ID: 17028849
[TBL] [Abstract][Full Text] [Related]
7. Determination of beta-adrenoceptor subtype on rat isolated ventricular myocytes by use of highly selective beta-antagonists.
Kitagawa Y; Adachi-Akahane S; Nagao T
Br J Pharmacol; 1995 Sep; 116(1):1635-43. PubMed ID: 8564230
[TBL] [Abstract][Full Text] [Related]
8. Validity of (-)-[3H]-CGP 12177A as a radioligand for the 'putative beta4-adrenoceptor' in rat atrium.
Sarsero D; Molenaar P; Kaumann AJ
Br J Pharmacol; 1998 Feb; 123(3):371-80. PubMed ID: 9504376
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of binding sites of CGP12177, a beta 3-adrenoceptor partial agonist, and carteolol, a beta 1/beta 2-adrenoceptor partial agonist, to the beta-adrenoceptors in guinea-pig taenia caecum.
Koike K; Takayanagi I; Yamazaki M
Can J Physiol Pharmacol; 1996 Aug; 74(8):928-33. PubMed ID: 8960382
[TBL] [Abstract][Full Text] [Related]
10. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Baker JG
Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528
[TBL] [Abstract][Full Text] [Related]
11. Abolition of (-)-CGP 12177-evoked cardiostimulation in double beta1/beta2-adrenoceptor knockout mice. Obligatory role of beta1-adrenoceptors for putative beta4-adrenoceptor pharmacology.
Kaumann AJ; Engelhardt S; Hein L; Molenaar P; Lohse M
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):87-93. PubMed ID: 11191841
[TBL] [Abstract][Full Text] [Related]
12. The selectivity of beta-adrenoceptor agonists at human beta1-, beta2- and beta3-adrenoceptors.
Baker JG
Br J Pharmacol; 2010 Jul; 160(5):1048-61. PubMed ID: 20590599
[TBL] [Abstract][Full Text] [Related]
13. Characterization of isoprenaline- and salmeterol-stimulated interactions between beta2-adrenoceptors and beta-arrestin 2 using beta-galactosidase complementation in C2C12 cells.
Carter AA; Hill SJ
J Pharmacol Exp Ther; 2005 Nov; 315(2):839-48. PubMed ID: 16051698
[TBL] [Abstract][Full Text] [Related]
14. Putative beta 4-adrenoceptors in rat ventricle mediate increases in contractile force and cell Ca2+: comparison with atrial receptors and relationship to (-)-[3H]-CGP 12177 binding.
Sarsero D; Molenaar P; Kaumann AJ; Freestone NS
Br J Pharmacol; 1999 Dec; 128(7):1445-60. PubMed ID: 10602323
[TBL] [Abstract][Full Text] [Related]
15. Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.
Joseph SS; Lynham JA; Molenaar P; Grace AA; Colledge WH; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):496-503. PubMed ID: 14608456
[TBL] [Abstract][Full Text] [Related]
16. Aspartate138 is required for the high-affinity ligand binding site but not for the low-affinity binding site of the beta1-adrenoceptor.
Joseph SS; Colledge WH; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2004 Sep; 370(3):223-6. PubMed ID: 15322738
[TBL] [Abstract][Full Text] [Related]
17. Characterization of mexiletine as an antagonist of beta-adrenoceptor in Chinese hamster ovary cells expressing cloned human beta-adrenoceptors.
Sakamoto K; Karikomi Y; Kubota Y; Nakahara T; Ishii K
Biochem Pharmacol; 2004 Mar; 67(5):815-22. PubMed ID: 15104234
[TBL] [Abstract][Full Text] [Related]
18. Characterization of beta 1- and beta 3-adrenoceptors in intact brown adipocytes of the rat.
D'Allaire F; Atgié C; Mauriège P; Simard PM; Bukowiecki LJ
Br J Pharmacol; 1995 Jan; 114(2):275-82. PubMed ID: 7881727
[TBL] [Abstract][Full Text] [Related]
19. A monoclonal antibody raised against a thermo-stabilised β
Soave M; Cseke G; Hutchings CJ; Brown AJH; Woolard J; Hill SJ
Biochem Pharmacol; 2018 Jan; 147():38-54. PubMed ID: 29102678
[TBL] [Abstract][Full Text] [Related]
20. Agonist and inverse agonist actions of beta-blockers at the human beta 2-adrenoceptor provide evidence for agonist-directed signaling.
Baker JG; Hall IP; Hill SJ
Mol Pharmacol; 2003 Dec; 64(6):1357-69. PubMed ID: 14645666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
